Bahl & Gaynor Inc Gsk PLC Transaction History

Bahl & Gaynor Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 02, 2021	SELL	$34.07 - $39.94 $388,772 - $455,755	-11,411 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$37.87 - $43.58 $25,865 - $29,765	683 Added 6.37%	11,411 $465,000
Q1 2020 May 26, 2020	BUY	$32.47 - $48.83 $348,338 - $523,848	10,728 New	10,728 $406,000
Q1 2020 May 15, 2020	SELL	$32.47 - $48.83 $380,873 - $572,775	-11,730 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$42.0 - $48.25 $13,398 - $15,391	319 Added 2.8%	11,730 $551,000

Q2 2019 Aug 12, 2019	SELL	$39.4 - $42.7 $1,182 - $1,281	-30 Reduced 0.26%	11,411 $457,000
Q1 2019 May 13, 2019	SELL	$38.57 - $42.69 $47,788 - $52,892	-1,239 Reduced 9.77%	11,441 $478,000
Q2 2018 Aug 14, 2018	SELL	$39.61 - $42.76 $612,330 - $661,026	-15,459 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$36.18 - $40.15 $4,631 - $5,139	128 Added 0.83%	15,459 $604,000
Q2 2017 Aug 11, 2017	SELL	N/A	-2,150 Reduced 12.3%	15,331 $661,000
Q2 2017 Aug 10, 2017	BUY	N/A	17,481	17,481 $673,000

175K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $78.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

Stay updated on Bahl & Gaynor Inc with notifications on news.